Beware of the sneeze

Patrick Yang; Christopher B. Toomey; Jonathan Lin; Don O. Kikkawa; Bobby S. Korn; Andrew Harrison

doi:10.1016/j.survophthal.2019.04.001

Beware of the sneeze

Patrick Yang, Christopher B. Toomey, Jonathan Lin, Don O. Kikkawa, Bobby S. Korn, Andrew Harrison

Ophthalmology & Visual Neurosciences

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1), also known as integrase interactor 1–deficient sinonasal carcinoma, is a rare entity that was first described in 2014. Since then, there have been 39 cases published in the literature, with basaloid or plasmacytoid/rhabdoid morphology being the most common pathological subtype. We report a patient with switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (integrase interactor 1)-deficient sinonasal carcinoma who had permanent vision loss after valsalva-induced acute hemorrhage and resultant orbital compartment syndrome.

Original language	English (US)
Pages (from-to)	592-596
Number of pages	5
Journal	Survey of Ophthalmology
Volume	65
Issue number	5
DOIs	https://doi.org/10.1016/j.survophthal.2019.04.001
State	Published - Sep 1 2020

Bibliographical note

Publisher Copyright:
© 2019 Elsevier Inc.

Keywords

SMARCB1
carcinoma
hemorrhage
orbital
sinonasal
valsalva

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.survophthal.2019.04.001

OpenUrl availability

Full text

Cite this

@article{db6b3e50df544e72abb1fdd4fc646ef2,

title = "Beware of the sneeze",

abstract = "Switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1), also known as integrase interactor 1–deficient sinonasal carcinoma, is a rare entity that was first described in 2014. Since then, there have been 39 cases published in the literature, with basaloid or plasmacytoid/rhabdoid morphology being the most common pathological subtype. We report a patient with switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (integrase interactor 1)-deficient sinonasal carcinoma who had permanent vision loss after valsalva-induced acute hemorrhage and resultant orbital compartment syndrome.",

keywords = "SMARCB1, carcinoma, hemorrhage, orbital, sinonasal, valsalva",

author = "Patrick Yang and Toomey, {Christopher B.} and Jonathan Lin and Kikkawa, {Don O.} and Korn, {Bobby S.} and Andrew Harrison",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.survophthal.2019.04.001",

language = "English (US)",

volume = "65",

pages = "592--596",

journal = "Survey of Ophthalmology",

issn = "0039-6257",

publisher = "Elsevier USA",

number = "5",

}

TY - JOUR

T1 - Beware of the sneeze

AU - Yang, Patrick

AU - Toomey, Christopher B.

AU - Lin, Jonathan

AU - Kikkawa, Don O.

AU - Korn, Bobby S.

AU - Harrison, Andrew

PY - 2020/9/1

Y1 - 2020/9/1

N2 - Switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1), also known as integrase interactor 1–deficient sinonasal carcinoma, is a rare entity that was first described in 2014. Since then, there have been 39 cases published in the literature, with basaloid or plasmacytoid/rhabdoid morphology being the most common pathological subtype. We report a patient with switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (integrase interactor 1)-deficient sinonasal carcinoma who had permanent vision loss after valsalva-induced acute hemorrhage and resultant orbital compartment syndrome.

AB - Switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1), also known as integrase interactor 1–deficient sinonasal carcinoma, is a rare entity that was first described in 2014. Since then, there have been 39 cases published in the literature, with basaloid or plasmacytoid/rhabdoid morphology being the most common pathological subtype. We report a patient with switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (integrase interactor 1)-deficient sinonasal carcinoma who had permanent vision loss after valsalva-induced acute hemorrhage and resultant orbital compartment syndrome.

KW - SMARCB1

KW - carcinoma

KW - hemorrhage

KW - orbital

KW - sinonasal

KW - valsalva

UR - http://www.scopus.com/inward/record.url?scp=85065129196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065129196&partnerID=8YFLogxK

U2 - 10.1016/j.survophthal.2019.04.001

DO - 10.1016/j.survophthal.2019.04.001

M3 - Article

C2 - 30978335

AN - SCOPUS:85065129196

SN - 0039-6257

VL - 65

SP - 592

EP - 596

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

IS - 5

ER -

Beware of the sneeze

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this